It would be interesting to evaluate the effects of niacin administration to mice that had attenuated circulating levels of adiponectin, such as in heterozygous Adipoq+/- mice, that may more accurately reflect the low, but not absent levels of adiponectin that are observed in people with obesity. This evidence concerns the gene ADIPOQ and obesity disorder.